Mouse models for mitochondrial diseases

被引:25
|
作者
Ruzzenente, Benedetta [1 ]
Rotig, Agnes [1 ]
Metodiev, Metodi D. [1 ]
机构
[1] Univ Paris 05, INSERM U1163, Sorbonne Paris Cite, Inst Imagine, 24 Blvd Montparnasse, F-75015 Paris, France
关键词
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DEFICIENCY; C-OXIDASE DEFICIENCY; TRANSFER-RNA; HYPERTROPHIC CARDIOMYOPATHY; EMBRYONIC LETHALITY; OXPHOS DEFICIENCIES; LACTIC-ACIDOSIS; MODIFIED MICE; MUTATIONS;
D O I
10.1093/hmg/ddw176
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial diseases are heterogeneous and incurable conditions typically resulting from deficient ATP production in the cells. Mice, owing to their genetic and physiological similarity to humans as well as their relatively easy maintenance and propagation, are extremely valuable for studying mitochondrial diseases and are also indispensable for the preclinical evaluation of novel therapies for these devastating conditions. Here, we review the recent exciting developments in the field focusing on mouse models for mitochondrial disease genes although models for genes not involved in the pathogenesis of mitochondrial disease and therapeutic proof-of-concept studies using mouse models are also discussed.
引用
收藏
页码:R115 / R122
页数:8
相关论文
共 50 条
  • [1] Attempts to understand the mechanisms of mitochondrial diseases: The reverse genetics of mouse models for mitochondrial disease
    Ishikawa, Kaori
    Nakada, Kazuto
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2021, 1865 (03):
  • [2] Mitochondrial diseases in man and mouse
    Science, 5407 (1482-1488):
  • [3] Mitochondrial diseases in man and mouse
    Wallace, DC
    SCIENCE, 1999, 283 (5407) : 1482 - 1488
  • [4] Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases
    Calingasan, N. Y.
    Ho, D. J.
    Wille, E. J.
    Campagna, M. V.
    Ruan, J.
    Dumont, M.
    Yang, L.
    Shi, Q.
    Gibson, G. E.
    Beal, M. F.
    NEUROSCIENCE, 2008, 153 (04) : 986 - 996
  • [5] Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies
    Peralta, Susana
    Torraco, Alessandra
    Iommarini, Luisa
    Diaz, Francisca
    MITOCHONDRION, 2015, 23 : 71 - 80
  • [6] iPSC models of mitochondrial diseases
    Heiduschka, Sonja
    Prigione, Alessandro
    NEUROBIOLOGY OF DISEASE, 2025, 207
  • [7] Mouse models for mitochondrial disease
    Wallace, DC
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (01): : 71 - 93
  • [8] Impact of Olesoxime on disease related mitochondrial membrane properties in mouse models of neurodegenerative diseases
    Eckmann, J.
    Eckert, S. H.
    Leuner, K.
    Bordet, T.
    Pruss, R.
    Grierson, A.
    Shaw, P.
    Clemens, L.
    Nguyen, H. P.
    Mueller, W. E.
    Eckert, G. P.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 51 - 51
  • [9] Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
    Fernandez-Checa, J. C.
    Fernandez, A.
    Morales, A.
    Mari, M.
    Garcia-Ruiz, C.
    Colell, A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 439 - 454
  • [10] Mouse models of oxidative phosphorylation defects: Powerful tools to study the pathobiology of mitochondrial diseases
    Torraco, Alessandra
    Diaz, Francisca
    Vempati, Uma D.
    Moraes, Carlos T.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (01): : 171 - 180